Oct. 07 2026
Source Page: Trastuzumab deruxtecan for treating HER2-low metastatic or unresectable breast cancer after chemotherapyOct. 07 2026
Source Page: Trastuzumab deruxtecan for treating HER2-low metastatic or unresectable breast cancer after chemotherapyOct. 06 2026
Source Page: Wyseforte Bank /wyseforte.co.ukOct. 06 2026
Source Page: VortexFX / www.vortexfx.comOct. 06 2026
Source Page: VFM Leasing (clone of FCA authorised firm)Oct. 06 2026
Source Page: CLAIMGRID LTDOct. 06 2026
Source Page: Looking at how we interact with whistleblowersOct. 05 2026
Source Page: Safe Wallet / greenbit.fit / safe-wallet.ioOct. 05 2026
Source Page: rosenman-lockeOct. 05 2026
Source Page: FCA Board minutes: 30 July 2026 [pdf]